Logo for Genmab

Genmab Investor Relations Material

Latest events

Logo for Genmab

Investor Update

Genmab
Logo for Genmab

Investor Update

10 Mar, 2025
Logo for Genmab

Q4 2024

12 Feb, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies

Latest reports from Genmab

Access all reports
Segment Data
Access more data
Revenue by
Type
Royalties
Milestone revenue
Reimbursement revenue
Collaboration revenue
License revenue
Expenses by
Financials
Genmab, a biotechnology company, develops antibody therapeutics for the treatment of cancer and other diseases primarily in Europe.